San Francisco Sentry Investment Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-250
Closed -$16K 706
2014
Q1
$16K Hold
250
0.01% 476
2013
Q4
$14K Hold
250
﹤0.01% 463
2013
Q3
$15K Hold
250
0.01% 436
2013
Q2
$15K Buy
+250
New +$15K 0.01% 439